In this free webinar, learn how pharmacovigilance professionals can apply practical solutions and advanced technologies to enhance their ability to efficiently monitor and respond to risks, ensure regulatory compliance, improve decision-making and ultimately safeguard public health. Attendees will learn how to adapt and apply risk management plans (RMPs) effectively across diverse healthcare systems while addressing the needs of healthcare professionals and patients. The featured speakers will discuss how to leverage digital tools and platforms to enhance RMP monitoring and implementation. The speakers will also share key methods to measure and monitor RMP/risk minimisation measures (RMM) effectiveness and more.

TORONTO, Aug. 19, 2024 /PRNewswire-PRWeb/ -- Pharmacovigilance professionals in pharma and biotech face the continuous challenge of balancing patient safety with ensuring patient access to medicinal products. Risk management plans (RMPs) and risk minimisation measures (RMMs) play a critical role in enabling and maintaining a favourable benefit–risk ratio.

As living documents, they require continual updates and adaptation to emerging risks, ongoing completion of pharmacovigilance activities and the seamless integration of RMMs.

RMPs must be implemented within specific timelines and remain inspection-ready. However, as living documents, they require continual updates and adaptation to emerging risks, ongoing completion of pharmacovigilance activities and the seamless integration of RMMs.

Navigating these demands can be challenging, particularly within the constraints of local health systems and the expectations of healthcare professionals and their patients.

In this webinar, the attendees will get to learn about practical solutions and advanced technologies to enhance their ability to efficiently monitor and respond to risks, ensure regulatory compliance, improve decision-making and ultimately safeguard public health. They will also gain insights into:

  • How to adapt and apply RMPs effectively across diverse healthcare systems while addressing the needs of healthcare professionals and patients
  • How to leverage digital tools and platforms to enhance RMP monitoring and implementation
  • The key methods to measure and monitor RMP/RMM effectiveness
  • How pharmacovigilance leadership, EU Qualified Person Responsible for Pharmacovigilance (QPPV) and Local Person for Pharmacovigilance (LPPV) can maintain appropriate oversight

Register for this webinar today for insights and knowledge that can help effectively navigate the digital transformation in pharmacovigilance.

Join experts from ICON, Steve Bowers, Director, Pharmacovigilance & Safety Services; and Rakan Bitar, Senior Director, Pharmacovigilance & Safety Services, for the live webinar on Thursday, September 12, 2024, at 11am EDT (4pm BST/UK).

For more information, or to register for this event, visit Mastering RMPs and RMMs: Tech-driven solutions for patient safety.

ABOUT XTALKS

Xtalks, powered by Honeycomb Worldwide Inc., is a leading provider of educational webinars and digital content to the global life science, food, healthcare and medical device communities. Every year, thousands of industry practitioners (from pharmaceutical, biotechnology, food, healthcare and medical device companies, private & academic research institutions, healthcare centers, etc.) turn to Xtalks for access to quality content. Xtalks helps professionals stay current with industry developments, regulations and jobs. Xtalks webinars also provide perspectives on key issues from top industry thought leaders and service providers.

To learn more about Xtalks visit https://xtalks.com
For information about hosting a webinar visit https://xtalks.com/why-host-a-webinar/

Media Contact

Vera Kovacevic, Xtalks, +1 (416) 977-6555 x371, vkovacevic@xtalks.com, https://xtalks.com

Cision View original content to download multimedia:https://www.prweb.com/releases/mastering-rmps-and-rmms-tech-driven-solutions-for-patient-safety-upcoming-webinar-hosted-by-xtalks-302224935.html

SOURCE Xtalks

Copyright 2024 PR Newswire